Turnaround: 3-5 business daysTurnaround: 7-10 business days
Price: $45.00Price: £40.00
Breeds: Collie, Mixed Breed, Rough Collie, Scotch Collie, Shetland Sheepdog, Smooth Collie, Unspecified
At a glance
- What it detects
- Three risk markers for dermatomyositis: the PAN2 (A) and MAP3K7CL (B) variants and the DLA-DRB1*002:01 type
- Inheritance
- Complex. The combination of the three markers sets low, moderate or high risk
- Possible results
- Low, moderate or high risk, based on the three markers
- Good to know
- Developed for Collies and Shetland Sheepdogs. The result shows risk, not a diagnosis
Description
Dermatomyositis (DMS) is a genetic disorder in which dogs’ skin, muscles, and blood vessels become inflamed. Dogs become weakened, develop skin lesions, and have an enlarged throat. Symptoms typically appear before the dog is six months old. There is no known cure for dermatomyositis, however, the effects of the disease can be lessened with proper management.
Dermatomyositis is an autosomal dominant disorder. This means that the mutated gene can be inherited from either parent (the disorder is not sex-linked) and only one copy of the gene is needed in order for symptoms to present themselves. Symptoms include:
- loss of muscle mass
- swelling of the esophagus
- skin lesions (especially around the face and tip of tail)
- skin ulcers (in extreme cases)
- dandruff/scaling skin due to skin irritation
- abnormal gait
- problems eating, drinking, and swallowing
- more prone to contracting pneumonia
Although there is no cure, dermatomyositis can be managed. Avoid letting your dog into bright sunlight, as ultraviolet rays can worsen skin lesions. A veterinarian may prescribe hypoallergenic shampoos, steroids to reduce inflammation, and vitamin-enriched special foods to improve skin health.
Detailed explanation of testing and test results from American Shetland Sheepdog Association (ASSA)
Possible results
Each result has three parts: the dog’s two DLA-DRB1 types, then its PAN2 (A/a) and MAP3K7CL (B/b) genotype. For example, 002:01 | 002:01 · AABB. Together they place the dog in one of three risk levels. Tap a risk level to see its combinations.
High RiskThe combination of markers puts the dog at high risk of developing dermatomyositis.See all 12 combinations
- 002:01 | 002:01AABB
- 002:01 | 002:01AABb
- 002:01 | 002:01AaBB
- 002:01 | 015:01AABB
- 002:01 | 023:01AABB
- 006:01 | 002:01AABB
- 006:01 | 006:01AABB
- 006:01 | 015:01AABB
- 006:01 | 023:01AABB
- 015:01 | 015:01AABB
- 023:01 | 015:01AABB
- 023:01 | 023:01AABB
Moderate RiskThe combination of markers puts the dog at moderate risk of developing dermatomyositis.See all 29 combinations
- 002:01 | 002:01AAbb
- 002:01 | 002:01aaBB
- 002:01 | 015:01AABb
- 002:01 | 015:01AAbb
- 002:01 | 015:01AaBB
- 002:01 | 023:01AABb
- 002:01 | 023:01AAbb
- 002:01 | 023:01AaBB
- 006:01 | 002:01AABb
- 006:01 | 002:01AAbb
- 006:01 | 002:01AaBB
- 006:01 | 006:01AABb
- 006:01 | 006:01AAbb
- 006:01 | 006:01AaBB
- 006:01 | 015:01AABb
- 006:01 | 015:01AAbb
- 006:01 | 015:01AaBB
- 006:01 | 023:01AABb
- 006:01 | 023:01AAbb
- 006:01 | 023:01AaBB
- 015:01 | 015:01AABb
- 015:01 | 015:01AAbb
- 015:01 | 015:01AaBB
- 023:01 | 015:01AABb
- 023:01 | 015:01AAbb
- 023:01 | 015:01AaBB
- 023:01 | 023:01AABb
- 023:01 | 023:01AAbb
- 023:01 | 023:01AaBB
Low RiskThe combination of markers puts the dog at low risk of developing dermatomyositis.See all 49 combinations
- 002:01 | 002:01AaBb
- 002:01 | 002:01Aabb
- 002:01 | 002:01aaBb
- 002:01 | 002:01aabb
- 002:01 | 015:01AaBb
- 002:01 | 015:01Aabb
- 002:01 | 015:01aaBB
- 002:01 | 015:01aaBb
- 002:01 | 015:01aabb
- 002:01 | 023:01AaBb
- 002:01 | 023:01Aabb
- 002:01 | 023:01aaBB
- 002:01 | 023:01aaBb
- 002:01 | 023:01aabb
- 006:01 | 002:01AaBb
- 006:01 | 002:01Aabb
- 006:01 | 002:01aaBB
- 006:01 | 002:01aaBb
- 006:01 | 002:01aabb
- 006:01 | 006:01AaBb
- 006:01 | 006:01Aabb
- 006:01 | 006:01aaBB
- 006:01 | 006:01aaBb
- 006:01 | 006:01aabb
- 006:01 | 015:01AaBb
- 006:01 | 015:01Aabb
- 006:01 | 015:01aaBB
- 006:01 | 015:01aaBb
- 006:01 | 015:01aabb
- 006:01 | 023:01AaBb
- 006:01 | 023:01Aabb
- 006:01 | 023:01aaBB
- 006:01 | 023:01aaBb
- 006:01 | 023:01aabb
- 015:01 | 015:01AaBb
- 015:01 | 015:01Aabb
- 015:01 | 015:01aaBB
- 015:01 | 015:01aaBb
- 015:01 | 015:01aabb
- 023:01 | 015:01AaBb
- 023:01 | 015:01Aabb
- 023:01 | 015:01aaBB
- 023:01 | 015:01aaBb
- 023:01 | 015:01aabb
- 023:01 | 023:01AaBb
- 023:01 | 023:01Aabb
- 023:01 | 023:01aaBB
- 023:01 | 023:01aaBb
- 023:01 | 023:01aabb
Reference
Evans JM, Noorai RE, Tsai KL, Starr-Moss AN, Hill CM, Anderson KJ, Famula TR, Clark LA. PLoS Genet. 2017 Feb 3;13(2):e1006604. doi: 10.1371/journal.pgen.1006604. eCollection 2017 Feb. [PMID: 28158183]
Related Tests
Ready to order this test?
